Nov
DEC
Jan
19
2014
2015
2016
1 captures
19 Dec 15 - 19 Dec 15
Close
Help
Skip to main content
Access brought to you by:
LOCKSS
Login
Search for this keyword
Advanced Search
Main menu
HOME
BROWSE BY CONFERENCE
BROWSE BY DISCIPLINE
-- All Disciplines --
Anesthesiology
Cardiology & Cardiovascular Medicine
Dentistry
Dermatology
Endocrinology, Diabetes & Metabolism
Emergency Medicine & Critical Care
Hematology
Hepatology
Infectious Diseases
Nephrology
Neurology
Nutrition
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopaedics & Sports Medicine
Psychiatry & Psychology
Pulmonary & Respiratory Medicine
Radiology
Rheumatology
Veterinary Medicine
ABOUT
About Us
International Medical Advisory Board
Reprints
Librarian resources
Contact us
Help
Featured Articles
Is it Time for Personalized Medicine in Atrial Fibrillation?
Guidelines
AHA/ACC Updates in the Treatment of Patients with Heart Failure
Guidelines for Prevention of Atherosclerotic Cardiovascular Disease
Clinical Trial Highlights
Prehospital Cooling Does Not Improve Outcomes in Cardiac Arrest
Lower-Temperature Target in Therapeutic Cooling Does Not Improve Outcomes
Results from the ROSE AHF Study
TOPCAT: Effects of Spironolactone on CV Outcomes in Patients with Heart Failure with Preserved Ejection Fraction
Adverse Effects Associated with Varespladib in the VISTA-16 Trial
Endovascular Revascularization Plus Supervised Exercise May Benefit Intermittent Claudication Patients
EU-PACT Study: Initial Warfarin Dosing Improved by Clinical Variables and Genotype to Guide Therapy
COAG Trial: No Advantage Seen with Genetic-Based Warfarin Dosing
No Benefit to Renal Artery Stenting Seen in CORAL Trial
Edoxaban Noninferior to Warfarin in the ENGAGE AF-TIMI 48 Trial
Immediate Targeted Blood Pressure Reduction Does Not Improve Outcomes in Acute Stroke
Selected Updates
Stroke Prevention in Atrial Fibrillation: The Roles of Anticoagulants, Devices, and Antidotes
Managing Patients with Heart Failure and Diabetes
CVD as the Result of Cancer Treatment
Other Peer-Reviewed Articles
Novel Oral Anticoagulants: Addressing the Clinical Conundra
Back to top
Previous
Next
Search for this keyword